Read September 2026Bioverse review
Wide gap between molecules
Semaglutide is $129 and tirzepatide $399, which is a far wider gap than most sellers put between them.
What Bioverse charges, and what it bills
One row per molecule and delivery route. Where the two figures differ, the struck number is what Bioverse leads with and the figure under it is what a buyer cannot get below. Both are published by the seller; neither is a walked checkout.
| Product | Per month | 6 months | As the dose rises |
|---|---|---|---|
| Semaglutide, injectionRead August 2026The seller does not state what happens as the dose rises. | $129 | $774 | The seller does not state what happens as the dose rises. |
| Tirzepatide, injectionRead August 2026The seller does not state what happens as the dose rises. | $399 | $2,394 | The seller does not state what happens as the dose rises. |
The 6-month column is the billed monthly figure multiplied by 6. It is arithmetic on published prices, not a forecast of a bill: a real six months also carries dose changes, labs and shipping, and those are covered below where Bioverse states them.
The bottom line
Bioverse publishes $129 a month for compounded semaglutide and $399 for tirzepatide, read August 2026. Both sit against struck anchors, at $289 and $449. The $270 gap between molecules is wide for this category.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How Bioverse publishes its prices
Six months at $129 is $774 on the semaglutide line. On tirzepatide it is $2,394. The gap is the story: $270 a month is more than most sellers charge for tirzepatide outright. A reader wanting the dual agonist should compare that figure widely before accepting it.
At a glance
- Category
- GLP-1 telehealth sellers
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $129/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What Bioverse is
Bioverse sells both molecules by injection. Two lines carry figures. Each is presented against a higher struck-through price.
How it works
The service is remote. Neither line states what happens as the dose rises. The anchors are presentation rather than price. What a buyer can rely on is the two published figures.
Branded or compounded
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where the money holds, and where it moves
Predictable
- The semaglutide figure is low
- Both lines carry a published price
- Anchor figures are shown, not implied
Moves, or is not stated
- The tirzepatide figure is high
- The molecule gap is unusually wide
- No dose behavior is published
- No state coverage list is recorded
Who this is worth it for
A buyer who wants semaglutide and will look elsewhere for tirzepatide.
Who should price elsewhere
A buyer wanting both molecules priced reasonably at one seller.
Priced against
Sellers to price beside Bioverse
- Believe Health
Buyers who want the rate pinned across a titration
See Believe Health → - Silhouette MD
Buyers starting at the lowest tier and prepared to ask what the next one costs
See Silhouette MD → 
Auren RxBuyers who want a low rate without a long commitment
See Auren Rx →
More GLP-1 telehealth sellers priced end to end: FrameworkGobyMedsGood Girl RxHe & She MDHealthOnHealthRX
Sponsored alternative
Synergy Rx
Buyers pricing an oral without starting an intake
Check Synergy Rx availability →Frequently asked
Why is tirzepatide so much more?
Are the struck prices real?
Does the rate hold at a higher dose?
Is Bioverse expensive compared with other GLP-1 telehealth sellers providers?
Or go back to the price desk and compare Bioverse against every seller on it.